Omega Therapeutics, Inc.
OMGAQ
$0.055
$0.0122.22%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.09% | 45.08% | 20.37% | 34.43% | 13.76% |
| Total Depreciation and Amortization | 66.26% | -66.30% | 38.94% | 35.44% | 41.11% |
| Total Amortization of Deferred Charges | -15.38% | 9.09% | 33.33% | -41.18% | 30.00% |
| Total Other Non-Cash Items | -24.57% | -29.56% | 47.76% | -6.99% | 3.06% |
| Change in Net Operating Assets | 51.42% | -37.30% | 147.37% | -127.31% | -91.53% |
| Cash from Operations | 39.16% | 45.55% | 58.01% | 29.49% | 7.24% |
| Capital Expenditure | 97.79% | 61.70% | -- | -280.48% | -120.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -77.32% | -85.50% | -100.00% |
| Cash from Investing | 97.79% | -101.65% | -79.75% | -87.88% | -106.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -71.43% | -100.00% | -99.95% | -99.66% | 75.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -17,950.00% | -608.22% | -102.68% | 177.30% | -300.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.89% | -1,523.80% | -124.79% | -122.12% | -66.88% |